返回
Developing small Cas9 hybrids using molecular modeling
DOI:10.1038/s41598-024-68107-1.png)
摘要
En 中文
The contraction of CAG/CTG repeats is an attractive approach to correct the mutation that causes at least 15 neuromuscular and neurodegenerative diseases, including Huntington's disease and Myotonic Dystrophy type 1. Contractions can be achieved in vivo using the Cas9 D10A nickase from Streptococcus pyogenes (SpCas9) using a single guide RNA (sgRNA) against the repeat tract. One hurdle on the path to the clinic is that SpCas9 is too large to be packaged together with its sgRNA into a single adeno-associated virus. Here we aimed to circumvent this problem using the smaller Cas9 orthologue, SlugCas9, and the Cas9 ancestor OgeuIscB. We found them to be ineffective in inducing contractions, despite their advertised PAM sequences being compatible with CAG/CTG repeats. Thus, we further developed smaller Cas9 hybrids, made of the PAM interacting domain of S. pyogenes and the catalytic domains of the smaller Cas9 orthologues. We also designed the cognate sgRNA hybrids using molecular dynamic simulations and binding energy calculations. We found that the four Cas9/sgRNA hybrid pairs tested in human cells failed to edit their target sequences. We conclude that in silico approaches can identify functional changes caused by point mutations but are not sufficient for designing larger scale complexes of Cas9/sgRNA hybrids.
Keyword:
Cas9
Molecular dynamics
Binding energy
Gene editing
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.9
论文数:
28.0W
被引数:
83.5W
机构
引用论文
Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems
MOLECULAR CELL
IF16.6
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsCrispr-cas核酸酶诱导人细胞高频脱靶诱变
NATURE BIOTECHNOLOGY
IF41.7
Minimizing carry-over PCR contamination in expanded CAG/CTG repeat instability applications
SCIENTIFIC REPORTS
IF3.9
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins通过递送纯化的Cas9核糖核蛋白在人类细胞中进行高效的RNA引导的基因组编辑
GENOME RESEARCH
IF5.5

